Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01139450 · ClinicalTrials.gov registry record · Phase 3
Study of 0417 Ointment in the Treatment of Atopic Dermatitis
A Phase 3 study, sponsored by Fougera Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 899
- Enrollment target
NCT01139450: Completed Phase 3 study, sponsored by Fougera Pharmaceuticals.
NCT01139450 is a Phase 3 study that has completed, run by Fougera Pharmaceuticals. The registered enrollment target is 899 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (16% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01139450, a Phase 3 study, has completed, sponsored by Fougera Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 899 participants
- Enrollment target
Study Summary
The aim of this trial is to assess the efficacy of 0417 Ointment in the Treatment of Atopic Dermatitis. Treatment medication will be administered as follows: Apply a thin layer of ointment to affected skin areas twice daily and rub in gently and completely. Study medication will be applied twice a day, approximately 12 hours apart, for approximately 4 weeks.
Interventions
- DRUG 0417
- DRUG Vehicle of 0417 test product
- DRUG Tacrolimus Ointment 0.03%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 899 participants |
| Start Date | 2008-01 |
| Est. Completion | 2009-08 |
| Phase | Phase 3 |
What the finished NCT01139450 record still lists
NCT01139450 is an interventional study that assigns participants to a tested intervention. The registered 899 participants enrollment target is mid-sized for trials with a published cap, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (16% higher).
The record links to 0 conditions, and to 3 interventions - of which 0417 is the first listed.
NCT01139450 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01139450 about?
NCT01139450 is a clinical study titled "Study of 0417 Ointment in the Treatment of Atopic Dermatitis". The aim of this trial is to assess the efficacy of 0417 Ointment in the Treatment of Atopic Dermatitis. Treatment medication will be administered as follows: Apply a thin layer of ointment to affected skin areas twice daily and rub in gently and completely. Study medication will be applied twice a ...
What is the current status of trial NCT01139450?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 899 participants. The study started on 2008-01. Estimated completion is 2009-08.
What interventions are being tested in trial NCT01139450?
The interventions under investigation include: 0417 (DRUG), Vehicle of 0417 test product (DRUG), Tacrolimus Ointment 0.03% (DRUG).
Who is sponsoring clinical trial NCT01139450?
This trial is sponsored by Fougera Pharmaceuticals, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01139450's enrollment target sits among peer trials
899 360th of 2000 higher than 1,640 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02352116 · 900 participants · NA
Evaluation of Post-PACU Pain Management in Pediatric Surgery
- NCT02414347 · 900 participants
F 18 T807 Tau PET Imaging of Alzheimer's Disease
- NCT02670408 · 900 participants
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
- NCT02960022 · 900 participants · Phase 2
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia